Article Type
Article
Changed
Tue, 09/26/2023 - 12:23
Display Headline
Digital Tools in the Management of IBS/Functional GI Disorders
Author(s)
Eric D. Shah, MD, MBA, FACG

Click to view more from Gastroenterology Data Trends 2023. 

References
  1. Hasan SS et al. Neurogastroenterol Motil. 2023;35(4):e14554. doi:10.1111/nmo.14554
  2. Peters SL et al. Neurogastroenterol Motil. 2023;35(4):e14533. doi:10.1111/nmo.14533
  3. Zhou C et al. Neurogastroenterol Motil. 2019;31(2):e13461. doi:10.1111/nmo.13461
  4. Staudacher HM et al. Nat Rev Gastroenterol Hepatol. 2023;1-15. doi:10.1038/s41575-023-00794-z
  5. Qin HY et al. World J Gastroenterol. 2014;20(39):14126-14131. doi:10.3748/wjg.v20.i39.14126
  6. Varjú P et al. PLoS One. 2017;12(8):e0182942. doi:10.1371/journal.pone.0182942
  7. Saleh ZM et al. Am J Gastroenterol. 2023. doi:10.14309/ajg.0000000000002220
  8. Yu C et al. Clin Transl Gastroenterol. 2022;13(9):e00515. doi:10.14309/ctg.0000000000000515
  9. Jagannath B et al. Inflamm Bowel Dis. 2020;26(10):1533-1542. doi:10.1093/ibd/izaa191
  10. Zhang H et al. J Nutr. 2023;153(4):924-939. doi:10.1016/j.tjnut.2023.01.026
  11. Karakan T et al. Gut Microbes. 2022;14(1):2138672. doi:10.1080/19490976.2022.2138672
  12. Kordi M et al. Inform Med Unlocked. 2022;29:100891. doi:10.1016/j.imu.2022.100891
  13. Gubatan J et al. World J Gastroenterol. 2021;27(17):1920-1935. doi:10.3748/wjg.v27.i17.1920
  14. Boucher EM et al. Expert Rev Med Devices. 2021;18(suppl 1):37-49. doi:10.1080/17434440.2021.2013200
  15. Babel A et al. Front Digit Health. 2021;3:669869. doi:10.3389/fdgth.2021.669869
Author and Disclosure Information

Associate Professor of Medicine
Director, GI Physiology Laboratory Division of
Gastroenterology and Hepatology
University of Michigan, Michigan Medicine
Ann Arbor, MI

Publications
GI and Hepatology News
Topics
IBD & Intestinal Disorders
Author(s)
Eric D. Shah, MD, MBA, FACG
Author(s)
Eric D. Shah, MD, MBA, FACG
Author and Disclosure Information

Associate Professor of Medicine
Director, GI Physiology Laboratory Division of
Gastroenterology and Hepatology
University of Michigan, Michigan Medicine
Ann Arbor, MI

Author and Disclosure Information

Associate Professor of Medicine
Director, GI Physiology Laboratory Division of
Gastroenterology and Hepatology
University of Michigan, Michigan Medicine
Ann Arbor, MI

Click to view more from Gastroenterology Data Trends 2023. 

Click to view more from Gastroenterology Data Trends 2023. 

References
  1. Hasan SS et al. Neurogastroenterol Motil. 2023;35(4):e14554. doi:10.1111/nmo.14554
  2. Peters SL et al. Neurogastroenterol Motil. 2023;35(4):e14533. doi:10.1111/nmo.14533
  3. Zhou C et al. Neurogastroenterol Motil. 2019;31(2):e13461. doi:10.1111/nmo.13461
  4. Staudacher HM et al. Nat Rev Gastroenterol Hepatol. 2023;1-15. doi:10.1038/s41575-023-00794-z
  5. Qin HY et al. World J Gastroenterol. 2014;20(39):14126-14131. doi:10.3748/wjg.v20.i39.14126
  6. Varjú P et al. PLoS One. 2017;12(8):e0182942. doi:10.1371/journal.pone.0182942
  7. Saleh ZM et al. Am J Gastroenterol. 2023. doi:10.14309/ajg.0000000000002220
  8. Yu C et al. Clin Transl Gastroenterol. 2022;13(9):e00515. doi:10.14309/ctg.0000000000000515
  9. Jagannath B et al. Inflamm Bowel Dis. 2020;26(10):1533-1542. doi:10.1093/ibd/izaa191
  10. Zhang H et al. J Nutr. 2023;153(4):924-939. doi:10.1016/j.tjnut.2023.01.026
  11. Karakan T et al. Gut Microbes. 2022;14(1):2138672. doi:10.1080/19490976.2022.2138672
  12. Kordi M et al. Inform Med Unlocked. 2022;29:100891. doi:10.1016/j.imu.2022.100891
  13. Gubatan J et al. World J Gastroenterol. 2021;27(17):1920-1935. doi:10.3748/wjg.v27.i17.1920
  14. Boucher EM et al. Expert Rev Med Devices. 2021;18(suppl 1):37-49. doi:10.1080/17434440.2021.2013200
  15. Babel A et al. Front Digit Health. 2021;3:669869. doi:10.3389/fdgth.2021.669869
References
  1. Hasan SS et al. Neurogastroenterol Motil. 2023;35(4):e14554. doi:10.1111/nmo.14554
  2. Peters SL et al. Neurogastroenterol Motil. 2023;35(4):e14533. doi:10.1111/nmo.14533
  3. Zhou C et al. Neurogastroenterol Motil. 2019;31(2):e13461. doi:10.1111/nmo.13461
  4. Staudacher HM et al. Nat Rev Gastroenterol Hepatol. 2023;1-15. doi:10.1038/s41575-023-00794-z
  5. Qin HY et al. World J Gastroenterol. 2014;20(39):14126-14131. doi:10.3748/wjg.v20.i39.14126
  6. Varjú P et al. PLoS One. 2017;12(8):e0182942. doi:10.1371/journal.pone.0182942
  7. Saleh ZM et al. Am J Gastroenterol. 2023. doi:10.14309/ajg.0000000000002220
  8. Yu C et al. Clin Transl Gastroenterol. 2022;13(9):e00515. doi:10.14309/ctg.0000000000000515
  9. Jagannath B et al. Inflamm Bowel Dis. 2020;26(10):1533-1542. doi:10.1093/ibd/izaa191
  10. Zhang H et al. J Nutr. 2023;153(4):924-939. doi:10.1016/j.tjnut.2023.01.026
  11. Karakan T et al. Gut Microbes. 2022;14(1):2138672. doi:10.1080/19490976.2022.2138672
  12. Kordi M et al. Inform Med Unlocked. 2022;29:100891. doi:10.1016/j.imu.2022.100891
  13. Gubatan J et al. World J Gastroenterol. 2021;27(17):1920-1935. doi:10.3748/wjg.v27.i17.1920
  14. Boucher EM et al. Expert Rev Med Devices. 2021;18(suppl 1):37-49. doi:10.1080/17434440.2021.2013200
  15. Babel A et al. Front Digit Health. 2021;3:669869. doi:10.3389/fdgth.2021.669869
Publications
GI and Hepatology News
Publications
GI and Hepatology News
Topics
IBD & Intestinal Disorders
Article Type
Article
Display Headline
Digital Tools in the Management of IBS/Functional GI Disorders
Display Headline
Digital Tools in the Management of IBS/Functional GI Disorders
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Slideshow
Gate On Date
Fri, 09/22/2023 - 15:45
Un-Gate On Date
Fri, 09/22/2023 - 15:45
Use ProPublica
CFC Schedule Remove Status
Fri, 09/22/2023 - 15:45
Hide sidebar & use full width
Do not render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Article Slideshow Optional Introduction

Slideshow below. 

IBS can be a highly debilitating condition that negatively affects a person’s quality of life. The recent emergence of digital tools designed to help patients and caregivers better manage IBS and functional GI disorders has facilitated the formation of a new health care model with an ever-evolving landscape. These tools range from mobile apps, virtual health platforms, and wearable devices, to the use of AI and digital therapeutics.

These tools serve several purposes—such as telehealth services, symptom tracking, food journals, cognitive behavioral therapy, gut-directed hypnotherapy, and patient education—and can help increase patients’ access to safe, effective treatments.1,2 Further, AI-driven tools can assist health care providers in facilitating more accurate diagnoses and creating
more personalized treatment plans.

Regular exercise, stress management, and low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) dietary strategies are often recommended as nonpharmacologic approaches to IBS management.3-6 With the assistance of digital tools, patients can not only receive care, but also gain disease-specific knowledge, self-manage their diet, track physical activity, monitor stress and IBS symptoms remotely, and improve their quality of life with this new and expanding type of health care model.

Slide
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Slide Media